Our Team

The Fibronostic Team Bios


Joined Fibronostics in February of 2018 as Chief Commercial Officer. Greg is a Medical Device executive with over 25 years of experience and extensive leadership roles in: Business Development, Strategic Marketing, Channel Development, Product launches, International Marketing, Strategic Account Management, Synergy Development and Sales Management, in both large and small companies.

Before joining Fibronostics he worked in leadership roles with 3si, a startup Healthcare IT company dedicated to patient safety in surgery; and most recently held a senior position with FlexPro, a project management firm in the life science space where he ran Business Development and Marketing.

Prior to those efforts Greg held several leadership positions at Johnson & Johnson’s Depuy Synthes division, including Account Director where he was responsible for Strategic Account Management at regional IDNs. In addition, Greg established and led the team that set up the Strategic Account effort for the Synthes CMF division.

The majority of Greg’s time at Depuy Synthes, was in the position of Director of Business Development where he was responsible for all aspects of the Business Development and Channel Development process for the CMF Division. He was actively involved in the acquisition and integration of J&J and Synthes, co leading a team to gain incremental value from the two organizations.

Greg is a graduate of Gettysburg College in Gettysburg PA, where he earned a BA in Business Administration. He has worked with Habitat for Humanity and served on a Township Public Safety Committee and Beach Preservation Committee. He has guest lectured at Tulane University; School of Science and Engineering, addressing their Bio Medical Entrepreneur program on challenges in Orthopedics and career ethics.

Hawley K. Linke, PhD
In 2014, after 25 years with the global healthcare and research leader, Abbott Laboratories, Hawley engaged with Fibronostics’ parent company, SPRIM, as a Consultant and Advisor for Research and Clinical Services to the SII group in Orlando, FL.  She joined the leadership team of Fibronostics in late 2017 as the Senior Director for Scientific Affairs.  

Hawley’s Abbott experience included seven years with Abbott Diagnostics, Hepatitis-AIDS department as a Sr. Scientist and group leader of the molecular biology team charged with identifying the agent for so-called non-A, non-B hepatitis (now, HCV).  Her investigations during that time also involved establishing a relationship between HCV infection and hepatocellular carcinoma (HCC) in a large primate model.

In the early 1990’s Hawley brought molecular biology to Abbott Nutrition (formerly Ross Laboratories).  During that time her contributions ranged from running a laboratory that developed genetically engineered novel molecules in production quantities suitable as the basic protein source for infants and children with inborn errors of metabolism; to creating transgenic mammals whose milk contained high levels (grams/liter) of an essential human hormone found naturally in breastmilk.  Beyond molecular biology she has led clinical studies in infant nutrition and supported an FDA submission that delivered the first ever US claim for medical efficacy in standard infant formula.  Other successful clinical outcomes and technology targets included allergy, otitis media, infant respiratory infections, human milk oligosaccharides, gastrointestinal symptom relief, probiotic modulation, necrotizing enterocolitis diagnostics for the NICU, metabolomics profiling, and human microbiome implications for nutrition strategies. She also has experience with prion agents and the CNS virus associated with progressive multifocal leukoencephalopathy (PML).  

Hawley received her AB degree in Zoology from San Diego State University; a doctorate in Molecular Biology for the University of California, Los Angeles; and served as a post-doctoral fellow in the Department of Pathology at the Stanford University School of Medicine.

High-performance CIO/CTO and visionary with over 28 years of strategically using of innovative technologies for start-up ventures through to global financial organizations to achieve business objectives. Keys to success include in-depth technology portfolio deployment expertise and ability to form highly collaborative partnerships with the business to further its objectives.

A proactive learner named as one of the Top 50 Best and Brightest Worldwide Executive MBA graduates in 2017  for the University of Toronto (U of T) Masters in Business Administration (MBA) along with University of Waterloo Systems Design Engineering degree. Real world experience in technology infrastructure and application deployment and proven track record of delivery on objectives.Leader in developing massively scalable technology-based startup ventures with equity value creation with focus on Machine Learning (ML) / Artificial Intelligence (AI), Virtual and Augmented Reality (VR/AR), and the Internet of Everything (IoE/IoT) at the U of T Rotman Technology based Creative Destruction Lab (CDL).

Calvin Cearley
Marketing Director

Experienced marketing thought leader and brand strategist with focus on digital channels and data driven optimization.

Len Mancini
Sales Director

Len has over 30 years of experience in the Medical Device Industry. He has extensive experience in sales, sales management, product development and business development.

Prior to joining Fibronostics, Len was the director of Business Development for Penblade, Inc. For 3 years he was the Vice President of New Business Development for 3si Systems, an IT based healthcare technology company. For 18 years Len was the President and Director of Sales and Marketing with Medcomp. He lead the company's product launches, new business development, built direct and manufacture rep sales forces that resulted in Medcomp becoming the number 1 market leader in vascular access products for the dialysis and infusion markets. Len is a graduate of Villanova University with BS degrees in Finance and Marketing. He serves as a mentor for students at the Business Institute for Entrepreneurship at Florida Gulf Coast University


Fibronostics Offices

Strategic locations for global coverage.

About Fibronostics

We are a team of life science experts, physicians, mathematicians, health IT professionals and software architects.

Orlando Offices

Singapore Offices